Susquehanna International Group’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $338K | Buy |
60,886
+44,795
| +278% | +$249K | ﹤0.01% | 4879 |
|
2025
Q1 | $69.2K | Sell |
16,091
-6,723
| -29% | -$28.9K | ﹤0.01% | 5954 |
|
2024
Q4 | $488K | Buy |
22,814
+2,294
| +11% | +$49K | ﹤0.01% | 4092 |
|
2024
Q3 | $386K | Buy |
+20,520
| New | +$386K | ﹤0.01% | 3987 |
|
2024
Q2 | – | Sell |
-8,084
| Closed | -$237K | – | 6150 |
|
2024
Q1 | $237K | Buy |
+8,084
| New | +$237K | ﹤0.01% | 4483 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 5969 |
|
2023
Q2 | – | Sell |
-1,382
| Closed | -$25K | – | 6105 |
|
2023
Q1 | $25K | Sell |
1,382
-2,055
| -60% | -$37.2K | ﹤0.01% | 5582 |
|
2022
Q4 | $16.3K | Buy |
+3,437
| New | +$16.3K | ﹤0.01% | 5401 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 6538 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 6260 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 6158 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 6138 |
|